These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 12843008
21. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. Nardelli-Haefliger D, Wirthner D, Schiller JT, Lowy DR, Hildesheim A, Ponci F, De Grandi P. J Natl Cancer Inst; 2003 Aug 06; 95(15):1128-37. PubMed ID: 12902442 [Abstract] [Full Text] [Related]
22. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. Bontkes HJ, de Gruijl TD, Walboomers JM, Schiller JT, Dillner J, Helmerhorst TJ, Verheijen RH, Scheper RJ, Meijer CJ. J Gen Virol; 1999 Feb 06; 80 ( Pt 2)():409-417. PubMed ID: 10073701 [Abstract] [Full Text] [Related]
24. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lowy D, Lorincz AT, Manos MM, Glass AG. J Infect Dis; 1995 Dec 06; 172(6):1425-30. PubMed ID: 7594698 [Abstract] [Full Text] [Related]
28. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia. Zumbach K, Kisseljov F, Sacharova O, Shaichaev G, Semjonova L, Pavlova L, Pawlita M. Int J Cancer; 2000 Feb 01; 85(3):313-8. PubMed ID: 10652419 [Abstract] [Full Text] [Related]
29. Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions. Strickler HD, Schiffman MH, Eklund C, Glass AG, Scott DR, Sherman ME, Wacholder S, Kurman RJ, Manos MM, Schiller JT, Dillner J. Cancer Epidemiol Biomarkers Prev; 1997 Mar 01; 6(3):183-8. PubMed ID: 9138661 [Abstract] [Full Text] [Related]
31. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer. Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB. J Virol; 2005 Jun 01; 79(11):6741-50. PubMed ID: 15890912 [Abstract] [Full Text] [Related]
32. Capture ElISA and in vitro cell binding assay for the detection of antibodies to human papillomavirus type 6b virus-like particles in patients with anogenital warts. Peng S, Qi Y, Christensen N, Hengst K, Kennedy L, Frazer IH, Tindle RW. Pathology; 1999 Nov 01; 31(4):418-22. PubMed ID: 10643018 [Abstract] [Full Text] [Related]
37. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. Han C, Qiao G, Hubbert NL, Li L, Sun C, Wang Y, Yan M, Xu D, Li Y, Lowy DR, Schiller JT. J Natl Cancer Inst; 1996 Oct 16; 88(20):1467-71. PubMed ID: 8841021 [Abstract] [Full Text] [Related]
38. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. Heino P, Eklund C, Fredriksson-Shanazarian V, Goldman S, Schiller JT, Dillner J. J Natl Cancer Inst; 1995 Mar 15; 87(6):437-40. PubMed ID: 7532227 [Abstract] [Full Text] [Related]